Clear insight into complex multimodal resins and impurities to overcome recombinant protein purification challenges: A review
- 18 September 2024
- journal article
- review article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 122 (1) , 5-29
Abstract
Increasing attention has been paid to the purity of therapeutic proteins imposing extensive costs and challenges to the downstream processing of biopharmaceuticals. One of the efforts, that has been exerted to overcome such limitations, was developing multimodal or mixed‐mode chromatography (MMC) resins for launching selective, orthogonal, non‐affinity purification platforms. Despite relatively extensive usage of MMC resins, their real potential and fulfillment have not been extensively reviewed yet. In this work, the explanation of practical and key aspects of downstream processing of recombinant proteins with or without MMC resins was debated, as being useful for further purification process development. This review has been written as a step‐by‐step guide to deconvolute both inherent protein purification and MMC complexities. Here, after complete elucidation of the potential of MMC resins, the effects of frequently used additives (mobile phase modifiers) and their possible interactions during the purification process, the critical characteristics of common product‐related impurities (e.g., aggregates, charge variants, fragments), host‐related impurities (e.g., host cell protein and DNA) and process related impurities (e.g., endotoxin, and viruses) with solved or unsolved challenges of traditional and MMC resins have been discussed. Such collective experiences which are reported in this study could be considered as an applied guide for developing successful downstream processing in challenging conditions by providing a clear insight into complex MMC resins and impurities.Keywords
This publication has 175 references indexed in Scilit:
- Identification and characterization of CHO host‐cell proteins in monoclonal antibody bioprocessingBiotechnology and Bioengineering, 2023
- Affinity Chromatography: An Enabling Technology for Large‐Scale BioprocessingBiotechnology Journal, 2019
- Integrated Chromatographic Platform for Simultaneous Separation of Charge Variants and Aggregates from Monoclonal Antibody Therapeutic ProductsBiotechnology Journal, 2017
- Overview of the Purification of Recombinant ProteinsCurrent Protocols in Protein Science, 2015
- Resolution of heterogeneous charged antibody aggregates via multimodal chromatography: A comparison to conventional approachesBiotechnology Progress, 2014
- Dual salt mixtures in mixed mode chromatography with an immobilized tryptophan ligand influence the removal of aggregated monoclonal antibodiesBiotechnology Journal, 2014
- Quality attributes of recombinant therapeutic proteins: An assessment of impact on safety and efficacy as part of a quality by design development approachBiotechnology Progress, 2012
- Mobile phase modifier effects in multimodal cation exchange chromatographyBiotechnology and Bioengineering, 2011
- Why Are Proteins Charged? Networks of Charge–Charge Interactions in Proteins Measured by Charge Ladders and Capillary ElectrophoresisAngewandte Chemie International Edition, 2006
- The recovery of the hepatitis B virus surface antigen (HBsAg) from a recombinant P. pastoris strain disruption and precipitation studiesActa Biotechnologica, 1993